- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04478955
Effect of Eye Make up on Ocular Surface
July 16, 2020 updated by: Zeynep Eylül Ercan, Erol Olcok Corum Training and Research Hospital
Effect of Pencil Eyeliners and Waterproof Mascara on Tear Stability Tests and Meibomography
The aim of this study is to compare the degree of tear film instability and severity of meibomian gland loss between subjects who use eyeliner, mascara, a combination of both and those who do not use eyeliner.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Corum, Turkey, 19000
- Recruiting
- ErolOlcok Corum WEducatin and Research Hospital
-
Contact:
- Zeynep E Ercan, MD
- Phone Number: 905322059636
- Email: zeynepeylul.ercan@saglik.gov.tr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
18 to 35 year old females with eyeliner, mascara or combined use for study groups 18 to 35 year old females with no make up use for control group
Description
Inclusion Criteria:
To use eyeliner/mascara or combined for at least 3 days for 6 months for study groups No routine eye make up use for the cıontrol group
-
Exclusion Criteria:
- any systemic or ocular disease taht can affect ocular surface
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
normal
no make up
|
Tear tests Meibomian gland grading test
Other Names:
|
eyeliner only
three days a week at least for 6 months
|
Tear tests Meibomian gland grading test
Other Names:
|
mascara only
three days a week at least for 6 months
|
Tear tests Meibomian gland grading test
Other Names:
|
eyeliner and mascara
three days a week at least for 6 months
|
Tear tests Meibomian gland grading test
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Schirmer test
Time Frame: 5 minutes
|
Tear measurement
|
5 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Non contact tear break up test
Time Frame: 17 seconds
|
tear stability calculation
|
17 seconds
|
Meibomography
Time Frame: 2 minutes
|
Meibomian gland loss grading
|
2 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2020
Primary Completion (Anticipated)
July 29, 2020
Study Completion (Anticipated)
August 1, 2020
Study Registration Dates
First Submitted
July 16, 2020
First Submitted That Met QC Criteria
July 16, 2020
First Posted (Actual)
July 21, 2020
Study Record Updates
Last Update Posted (Actual)
July 21, 2020
Last Update Submitted That Met QC Criteria
July 16, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Corum State Hospital
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Meibomian Gland Dysfunction
-
Hovione Scientia LimitedCompletedMeibomian Gland Dysfunction | MGD-Meibomian Gland DysfunctionUnited States
-
University of WaterlooCompletedMeibomian Gland Dysfunction (MGD)Canada
-
Aier School of Ophthalmology, Central South UniversityUnknownMeibomian Gland Massage is Important to Delay the Development of Meibomian Gland DysfunctionChina
-
Second Affiliated Hospital, School of Medicine,...Aier Eye Hospital, WuhanCompletedMGD-Meibomian Gland DysfunctionChina
-
Barzilai Medical CenterCompletedMGD-Meibomian Gland DysfunctionIsrael
-
Singapore National Eye CentreNational University, SingaporeCompleted
-
Johnson & Johnson Surgical Vision, Inc.CompletedCataracts | Meibomian Gland Dysfunction (MGD)United States
-
Azura OphthalmicsThe University of New South WalesCompletedMeibomian Gland Dysfunction (MGD) | Contact Lens Discomfort (CLD)Australia
-
Zhongnan HospitalRecruitingDry Eye | MGD-Meibomian Gland DysfunctionChina
-
Zhongnan HospitalRecruitingDry Eye | Positron-Emission Tomography | MGD-Meibomian Gland DysfunctionChina
Clinical Trials on Schirmer test
-
G. d'Annunzio UniversityUnknown
-
University Hospital, Clermont-FerrandCompletedDry Eye Syndrome | Ocular Surface DiseaseFrance
-
Helse Stavanger HFTor Paaske Utheim; Vegard Asgeir Forsaa; Vilde Marie ThomsethEnrolling by invitation
-
University Hospital, Clermont-FerrandRecruitingRheumatoid Arthritis | Sjogren's Syndrome | Sicca, Asthenia, Polyalgia Syndrome (SAPS)France
-
Namida LabRecruitingBreast Cancer ScreeningUnited States
-
Namida LabEnrolling by invitationHealthy | Breast Cancer | Health Knowledge, Attitudes, Practice | Health Care Utilization | Breast Cancer Female | Health Personnel Attitude | Health Care AcceptabilityUnited States
-
Namida LabThe University of Texas Medical Branch, GalvestonActive, not recruitingBreast Cancer | Breast Cancer Female | TearUnited States
-
Kahramanmaras Sutcu Imam UniversityCompletedEye Diseases | Dry Eye | Ocular Surface DiseaseTurkey
-
Namida LabArkansas Urology; CARTIEnrolling by invitationMelanoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate CancerUnited States
-
Democritus University of ThraceCompletedGlaucoma | Ocular Surface Disease | Glaucoma; DrugsGreece